Buttigliero C - Search Results

1

Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.

Buttigliero C, Pisano C, Tucci M, Vignani F, Bertaglia V, Iaconis D, Guglielmini P, Numico G, Scagliotti GV, Di Maio M. Buttigliero C, et al. Acta Oncol. 2017 Apr;56(4):555-562. doi: 10.1080/0284186X.2016.1260772. Epub 2017 Jan 9. Acta Oncol. 2017. PMID: 28068151

2

Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration.

Berruti A, Cook R, Saad F, Buttigliero C, Lipton A, Tampellini M, Lee KA, Coleman RE, Smith MR. Berruti A, et al. Among authors: buttigliero c. Oncologist. 2012;17(5):645-52. doi: 10.1634/theoncologist.2011-0448. Epub 2012 Apr 20. Oncologist. 2012. PMID: 22523198 Free PMC article. Clinical Trial.

3

Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer.

Bertaglia V, Tucci M, Fiori C, Aroasio E, Poggio M, Buttigliero C, Grande S, Saini A, Porpiglia F, Berruti A. Bertaglia V, et al. Among authors: buttigliero c. Clin Genitourin Cancer. 2013 Sep;11(3):325-330.e1. doi: 10.1016/j.clgc.2013.01.002. Epub 2013 Mar 23. Clin Genitourin Cancer. 2013. PMID: 23531429

4

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

Caffo O, De Giorgi U, Fratino L, Alesini D, Zagonel V, Facchini G, Gasparro D, Ortega C, Tucci M, Verderame F, Campadelli E, Lo Re G, Procopio G, Sabbatini R, Donini M, Morelli F, Sartori D, Zucali P, Carrozza F, D'Angelo A, Vicario G, Massari F, Santini D, Sava T, Messina C, Fornarini G, La Torre L, Ricotta R, Aieta M, Mucciarini C, Zustovich F, Macrini S, Burgio SL, Santarossa S, D'Aniello C, Basso U, Tarasconi S, Cortesi E, Buttigliero C, Ruatta F, Veccia A, Conteduca V, Maines F, Galligioni E. Caffo O, et al. Among authors: buttigliero c. Eur Urol. 2015 Jul;68(1):147-53. doi: 10.1016/j.eururo.2014.10.014. Epub 2014 Oct 25. Eur Urol. 2015. PMID: 25457020

5

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.

Buttigliero C, Vana F, Bertaglia V, Vignani F, Fiori C, Osella G, Porpiglia F, Tucci M, Scagliotti GV, Berruti A. Buttigliero C, et al. Endocrine. 2015 Sep;50(1):223-30. doi: 10.1007/s12020-015-0525-x. Epub 2015 Jan 15. Endocrine. 2015. PMID: 25588772 Free article.

6

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

Iuliani M, Pantano F, Buttigliero C, Fioramonti M, Bertaglia V, Vincenzi B, Zoccoli A, Ribelli G, Tucci M, Vignani F, Berruti A, Scagliotti GV, Tonini G, Santini D. Iuliani M, et al. Among authors: buttigliero c. Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724. Oncotarget. 2015. PMID: 25904051 Free PMC article.

7

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer.

Buttigliero C, Tucci M, Bertaglia V, Vignani F, Bironzo P, Di Maio M, Scagliotti GV. Buttigliero C, et al. Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31. Cancer Treat Rev. 2015. PMID: 26342718 Free article. Review.

8

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.

Tucci M, Bertaglia V, Vignani F, Buttigliero C, Fiori C, Porpiglia F, Scagliotti GV, Di Maio M. Tucci M, et al. Among authors: buttigliero c. Eur Urol. 2016 Apr;69(4):563-573. doi: 10.1016/j.eururo.2015.09.013. Epub 2015 Sep 28. Eur Urol. 2016. PMID: 26422676 Free article. Review.

9

Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.

Duregon E, Volante M, Bollito E, Goia M, Buttigliero C, Zaggia B, Berruti A, Scagliotti GV, Papotti M. Duregon E, et al. Among authors: buttigliero c. Hum Pathol. 2015 Dec;46(12):1799-807. doi: 10.1016/j.humpath.2015.08.012. Epub 2015 Sep 11. Hum Pathol. 2015. PMID: 26472162

10

Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.

Lo Iacono M, Buttigliero C, Monica V, Bollito E, Garrou D, Cappia S, Rapa I, Vignani F, Bertaglia V, Fiori C, Papotti M, Volante M, Scagliotti GV, Porpiglia F, Tucci M. Lo Iacono M, et al. Among authors: buttigliero c. Oncotarget. 2016 Mar 22;7(12):14394-404. doi: 10.18632/oncotarget.7343. Oncotarget. 2016. PMID: 26887047 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters